Amela Begić

Amela Begić

Auto-generated profile, based on publicly available information

Amela Begić

Clinical Centre of the University of Sarajevo

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
ABAmela Begic
Amela Begic
JJJonas Jögi
Jonas Jögi
AHAmra Hadziredzepovic
Amra Hadziredzepovic
EKElma Kucukalic-Selimović
Elma Kucukalic-Selimović
SBSadzida Begovic-Hadzimuratovic
Sadzida Begovic-Hadzimuratovic
MBMarika Bajc
Marika Bajc
Pulmonary embolism (PE) is a severe condition with nonspecific symptoms. Diagnosis relies on medical imaging but follow-up is currently based on clinical symptoms and general risk factors. The duration of anticoagulant treatment after an acute episode of PE is still subject to debate and the best method of identifying the risk of recurrence in individual patients is undefined. Tomographic lung scintigraphy [ventilation/perfusion single photon emission computed tomography (V/P SPECT)] has improved the diagnostic accuracy with regard to PE but has not been evaluated for PE follow-up. The aim of this prospective study was to quantitatively follow the natural history of treated PE using V/P SPECT, which could prove helpful in defining an anticoagulant treatment regime for individual patients. Of 83 consecutive patients with clinically suspected PE examined with V/P SPECT, 23 patients with confirmed PE were followed by serial V/P SPECT examinations over a 6-month period. All patients were also followed clinically. The mean relative decrease in PE extent compared with the time of diagnosis was 54±26% at 2 weeks, 79±30% at 3 months, and 82±30% at 6 months. Significant resolution of mismatched perfusion defects occurred between V/P SPECT controls within the first 3 months of anticoagulation (P<0.001) but not thereafter. V/P SPECT identified four patients with chronic PE, even though all patients were free from symptoms at 3-month follow-up. Follow-up of PE with V/P SPECT is feasible to evaluate treatment effectiveness in individual patients and to identify patients that develop chronic PE. This study also confirms that resolution of perfusion defects after PE occurs within the first 3 months of treatment. It is therefore recommended that V/P SPECT follow-up should be considered at 3 months after diagnosis.

22 September 2019 in Medicinski Glasnik
Verified
Journal Article
Closed access
ABAlden Begić
Alden Begić
ABAmela Begić
Amela Begić
AAAjla Arnautović-Halimić
Ajla Arnautović-Halimić
Aim To investigate the relations between hormonal status of the thyroid gland and mineral bone density in women in menopause with or without osteoporosis. MethodsThe study included 120 postmenopausal women, who were divided into two groups. Group I included postmenopausal patients with osteoporosis, of whom 30 were in the early stages of postmenopause, and 30 of them where in the late postmenopausal phase. The second group included patients with preserved bone mass, of which 30 were in the early stage of postmenopause, and 30 were in the late postmenopausal phase. Bone densitometry (DEXA) was performed for all patients, along with analysis of the level of follicle-stimulating hormone (FSH), thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3). ResultsA statistically significant correlation between TSH level and mineral bone density in the lumbar spine level (r=0.27) was found in early postmenopausal women (r <0.05), TSH and T-score at the level of the lumbar spine (r=0.31) (p<0.05), as well as between TSH and mineral content of the femur bone (r=0.29; <0.05). There was statistically significant independent association between thyroxine and mineral bone density at the lumbar spine level in the late postmenopausal women (ß=0.29; p=0.025). Conclusion In the early postmenopausal phase, TSH was associated with mineral bone density in the lumbar spine and in the area of the femur.

25 July 2019 in International Journal of Scientific & Engineering Research
Verified
Journal Article
Closed access
MBMelika Bukvić
Melika Bukvić
EZEnver Zerem
Enver Zerem
ABAmela Begić
Amela Begić
AMAmila Mehmedović
Amila Mehmedović
SVSandra Vegar-Zubović
Sandra Vegar-Zubović
FJFuad Julardžija
Fuad Julardžija

18 October 2026 in Konferencija radioloških tehnoogija s međunarodnim učešćem - CORT
Verified
Journal Article
Closed access
SHSafet Hadžimusić
Safet Hadžimusić
ABAmela Begić
Amela Begić
ABAdnan Beganović
Adnan Beganović
ŠCŠejla Cerić
Šejla Cerić
ASAmra Skopljak-Beganović
Amra Skopljak-Beganović
BTBelma Tukić
Belma Tukić
Uvod: Tjelesna masa značajno utiče na vrijednosti standardizovanog preuzimanja radiofarmaka (SUV) u PET/CT dijagnostici, zbog čega postoji potreba za preciznijim metodama kvantifikacije. U ovom istraživanju razvijen je dodatni modul od pčelinjeg voska koji je postavljen na standardni NEMA IQ fantom s ciljem simulacije povećane tjelesne mase pacijenata. Pčelinji vosak je odabran zbog svojih fizičkih i radioloških karakteristika koje su slične masnom tkivu. Metode: PET/CT snimanja provedena su korištenjem standardnog fantoma, kao i fantoma obloženog slojem pčelinjeg voska, uz primjenu identičnih niskodoznih protokola snimanja. Rekonstrukcija podataka izvršena je primjenom tri različite rekonstrukcione metode. Kvantitativna analiza bila je usmjerena na preuzimanje ¹⁸F-FDG u četiri „vruće“ sfere promjera od 10 do 37 mm. Posebna pažnja posvećena je parametrima SUVmax i SUVmean kako bi se procijenio uticaj modula od pčelinjeg voska na tačnost i ponovljivost mjerenja. Rezultati: Uočene su značajne razlike u SUV vrijednostima između standardnog fantoma i fantoma sa dodatnim slojem pčelinjeg voska, naročito pri primjeni različitih rekonstrukcionih parametara. Dobijeni rezultati potvrđuju da modul od pčelinjeg voska predstavlja pouzdan model za simulaciju povećane tjelesne mase te ukazuju na njegov potencijal u optimizaciji PET/CT protokola kod pacijenata sa povećanom tjelesnom težinom i gojaznošću. Zaključak: Vrijednosti SUVmean bile su više kod fantoma sa dodatkom pčelinjeg voska, što ukazuje na uticaj povećane tjelesne mase na kvantifikaciju PET signala. Međutim, korekcija na nemasnu tjelesnu masu (SUVlbm) značajno je smanjila ove razlike, potvrđujući da se uočen efekat prvenstveno odnosi na način izračuna SUV vrijednosti, a ne na stvarnu koncentraciju radiofarmaka. Rezultati naglašavaju važnost primjene odgovarajućih korekcija SUV parametara te podržavaju razvoj preciznijih PET/CT protokola prilagođenih promjenama tjelesne kompozicije, posebno u praćenju onkoloških pacijenata. Modul od pčelinjeg voska pokazao se kao jednostavan i praktičan alat za unapređenje kvantifikacije PET/CT nalaza kod različitih kategorija pacijenata.